Navigation Links
Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
Date:4/10/2013

NEWBURY PARK, Calif., April 10, 2013 /PRNewswire/ -- As Croatia prepares to join the European Union (EU) on July 1, global and regional life sciences companies are facing regulatory and compliance deadlines in accordance with EU European Medicines Agency (EMA) standards.

(Logo: http://photos.prnewswire.com/prnh/20121012/DA92092LOGO)

The EMA legally requires that pharmaceutical companies using the EMA's centralized marketing authorization procedure make their product information available in any new EU member's official language as of the member's date of accession. This means companies must accurately localize and translate all product labels and documentation into Croatian before July 1, otherwise they cannot market those products in the EU.

Moravia, a leading globalization company that helped pioneer localization in Croatia, says time is running out before the EMA's pending April 30 deadline for companies to submit translated documents and labels for verification. Any information sent past that deadline might not be certified by the EMA before Croatia's accession date, causing delay and missed marketing opportunities.

"Due to the size of the language, there is a limited pool of Croatian translators that can provide accurate product information translations. Therefore, it's important that companies choose a quality partner to help them smoothly navigate the EMA process," said Renato Beninatto , Chief Marketing Officer at Moravia. "Time is of the essence for companies trying to meet the Croatia accession deadlines. But new translation technologies available through providers like Moravia can help ensure fast project turnaround and delay-free regulatory approval."

A translation leader in the life sciences industry, Moravia holds ISO 13485 and EN 15038 certifications that illustrate the company's commitment to the industry's global standards.

About Moravia

Moravia is a leading globalization solution provider, enabling companies in the information technology, e-learning, and life sciences industries to enter global markets with high-quality multilingual products. Moravia's solutions include localization, product testing, internationalization, multilingual publishing, technical translation, content creation, machine translation, and workflow consulting. The company maintains global headquarters in the Czech Republic and North American headquarters in California, with local offices and production centers in Japan, China, Latin America, Ireland, USA and throughout Europe. www.moravia.com.

 


'/>"/>
SOURCE Moravia
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
2. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
3. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
4. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
5. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
6. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
7. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
8. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
9. TPI Provides Further Updates on its GMOL Flagship Product
10. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
11. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... LOS ANGELES , Feb. 10, 2016  Oxis ... blood cancer drug, OXS-1550, was described as a "clinical ... with the drug went into complete cancer remission. ... the University of Minnesota Masonic Cancer Center. ... the University of Minnesota Masonic Cancer Center. ...
(Date:2/10/2016)... Feb. 10, 2016  LexisNexis® Risk Solutions, a ... announced the launch of LexisNexis Provider Performance ... helps improve and optimize the quality and efficiency ... using severity-adjusted scores. By measuring provider performance through ... to deliver better outcomes, improve the patient experience ...
(Date:2/10/2016)... and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the field ... D investment round on February 5, 2016. The $15 ... ("Haisco"), a leading Chinese pharmaceutical manufacturer, and was ... Vitalife Partners, Generali Financial Holdings and both the Technion ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is ... leading bottled water brand owners that topped the list as a result of their ... conversion. The premier brand was Tibet 5100, a top notch water company that specializes ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... Ongoing ... the Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer ... experts released today illustrates the prevalence and causes of TBI among the aging population, ...
(Date:2/10/2016)... ... 10, 2016 , ... Gout is like no other joint pain. It strikes ... with intense swelling and redness. It is triggered by the crystallization of uric acid ... the most susceptible, according to the February 2016 issue of Harvard Men's Health Watch. ...
Breaking Medicine News(10 mins):